Collectively, these studies show that by directly or indirectly affecting innate and adaptive lymphoid cells (ILC2 and Th2 cells, as well as Treg cells) and myeloid cells, including macrophages and mast cells, IL-33 is involved in several pathological conditions associated with type 2 responses, including allergies, infections, inflammation and cancer. Here, IL33 is linked to infection.